✦ LIBER ✦

Infection in the adult today (what the radiologist needs to know)

✍ Scribed by Stephen J. Golding

Publisher: Springer
Year: 2004
Tongue: English
Weight: 108 KB
Volume: 14
Category: Article
ISSN: 1613-3749
DOI: 10.1007/s00330-003-2199-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Psychosocial issues in pediatric oncolog

Psychosocial issues in pediatric oncology: what the radiologist needs to know

✍ R. B. Gunderman 📂 Article 📅 2000 🏛 Springer-Verlag 🌐 English ⚖ 74 KB

GPIIb-IIIa Receptor Inhibitors: What the

GPIIb-IIIa Receptor Inhibitors: What the Interventional Radiologist Needs to Know

✍ Lawrence V. Hofmann; Mahmood Razavi; Aravind Arepally; Joel P. Reginelli; Jon Re 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 313 KB

Crohn’s disease clinical issues and trea

Crohn’s disease clinical issues and treatment: what the radiologist needs to know and what the gastroenterologist wants to know

✍ David H. Bruining; Edward V. Loftus 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 228 KB

Nephrogenic systemic fibrosis: What the

Nephrogenic systemic fibrosis: What the hospitalist needs to know

✍ Derek M. Fine; Mark A. Perazella 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

## Abstract Nephrogenic systemic fibrosis (NSF) has now been linked to gadolinium‐based contrast (GBC) exposure in those with compromised kidney function, particularly those with end‐stage renal disease (ESRD). When ESRD is present, symptoms can be quite devastating for the patient including severe

What the orthopedist needs to know about

What the orthopedist needs to know about training theory

✍ W. O. Frey; R. Zenhäusern 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 German ⚖ 330 KB

Tuberculosis in the cytokine era: What r

Tuberculosis in the cytokine era: What rheumatologists need to know

✍ Carol Dukes Hamilton 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

Anticytokine agents and other biologic response modifiers represent an important advance in the treatment of rheumatoid arthritis (RA) and other inflammatory diseases. While these agents are specific in their targets, they are not precise enough in their actions to avoid the negative consequences of